Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults

By L. Mandell, J. Bartlett, S. Dowell, T. File, D. Musher, C. Whitney. Clinical Infectious Diseases, 2003

1,005 citations recorded by the source corpus.

The Infectious Diseases Society of America (IDSA) produced guidelines for community-acquired pneumonia (CAP) in immunocompetent adults in 1998 and again in 2000 [1, 2]. Because of evolving resistance to antimicrobials and other advances, it was felt that an update should be provided every few years so that important developments could be highlighted and pressing questions answered. We addressed those issues that the committee believed were important to the practicing physician, including suggestions for initial empiric therapy for CAP. In some cases, only a few paragraphs were needed, whereas, in others, a somewhat more in-depth discussion was provided. Because many physicians focus on the tables rather than on the text of guidelines, it was decided that all of the information dealing with the initial empiric treatment regimens should be in tabular format with footnotes (tables 1–3). The topics selected for updating have been organized according to the headings used in the August 2000 CAP guidelines pub-

Subfields: Epidemiology

View Paper: https://www.semanticscholar.org/paper/06ddeca8d1261c145a40d2d082990351a2688f21

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Jonathan Cohen
2. Thierry Calandra

Citations in the corpus

• Updated Review of Blood Culture Contamination (2006, background): “Finally, the question of whether or not all patients hospitalized for community-acquired pneumonia require pretreatment blood cultures, as recommended by consensus guidelines (73, 91), has become intensely debated in recent years (20a, 52a).”
• Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. (2006, methodology): “Fourth, the mean duration of antibiotic therapy of 13 d in the control group appears rather long, as more recent guidelines recommend a duration of antibiotic therapy in CAP of 7 to 10 d (2, 8, 9).”
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007, methodology): “previous IDSA CAP guidelines [9], whereas ATS members were”
• Clinical and economic burden of community-acquired pneumonia among adults in Europe (2010, background): “These vaccines may prevent a substantial proportion of the overall burden of CAP.”
• The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit (2005, background): “, Mycobacterium tuberculosis, Legionella species, influenza virus, or Pneumocystis jiroveci (carinii); c) recovery of a likely/possible respiratory pathogen in high concentrations using quantitative cultures of a lower respiratory tract sample (endotracheal aspirate, BAL, or protected specimen brush”
• Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. (2005, background): “Shorter courses of antibiotic therapy should be considered—for instance, for patients with pneumonia or intra-abdominal infections [30, 31].”